AGN-211745
- Generic Name
- AGN-211745
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
Phase 2
Terminated
- Conditions
- Choroid NeovascularizationAge-Related Macular Degeneration
- Interventions
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Allergan
- Target Recruit Count
- 138
- Registration Number
- NCT00395057
A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Phase 1
Completed
- Conditions
- Age-Related Macular DegenerationChoroidal Neovascularization
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2008-08-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 26
- Registration Number
- NCT00363714
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath